{"product_id":"office-based-buprenorphine-treatment-of-opioid-use-disorder-9781615370832","title":"Office-Based Buprenorphine Treatment of Opioid Use Disorder","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eWith a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of \u003ci\u003eOffice-Based Buprenorphine Treatment of Opioid Use Disorder\u003c\/i\u003e provides updated information on evidence-based treatment for opioid use disorder (OUD)—an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States.\u003c\/p\u003e \t\t\t\t\t\u003cp\u003eBulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice.\u003c\/p\u003e \t\t\t\t\t\u003cp\u003eThis new edition of \u003ci\u003eOffice-Based Buprenorphine Treatment \u003c\/i\u003ehas been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy.\u003c\/p\u003e \t\t\t\t\t\u003cp\u003eAmong the numerous other revisions included in the second edition are the following:   \u003cbr\u003e• Information about new formulations of buprenorphine\u003cbr\u003e• A discussion of the Comprehensive Addiction and Recovery Act (CARA)\u003cbr\u003e• Changes to induction and maintenance target doses and recommendations for home inductions\u003cbr\u003e• Information on diversion control plans\u003cbr\u003e• Advice for working with Alcoholics Anonymous and Narcotics Anonymous\u003cbr\u003e• A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs  \u003c\/p\u003e \t\t\t\t\t\u003cp\u003eThis edition can also be used to complete the 8 hours of qualifying training required for the buprenorphine waiver. By a thorough reading of the material covered in the chapters of this book and successful completion of the posttest, physicians can meet the buprenorphine waiver training requirement.\u003c\/p\u003e \t\t\t\t\t\u003cp\u003eWritten in a jargon-free style that does not require expertise in substance use disorder treatment,\u003ci\u003e Office-Based Buprenorphine Treatment of Opioid Use Disorder\u003c\/i\u003e is an accessible, indispensable reference for primary care physicians, psychiatrists, nurse practitioners, residents, medical students, and anyone with an interest in learning about and prescribing buprenorphine.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis book provides good clinical guidance for those interested in offering medication-assisted treatments for this patient population. An added bonus is that this book can be used to complete the qualifying training required for the buprenorphine waiver.\u003c\/p\u003e -- Michael Easton, M.D. * Doody's Book Review *\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eContributors\u003cbr\u003eDedication\u003cbr\u003eForeword\u003cbr\u003eObtaining the Buprenorphine Waiver\u003cbr\u003eChapter 1. Opioid Use Disorder in America: History and Overview\u003cbr\u003eChapter 2. General Opioid Pharmacology\u003cbr\u003eChapter 3. Efficacy and Safety of Buprenorphine\u003cbr\u003eChapter 4. Patient Assessment\u003cbr\u003eChapter 5. Clinical Use of Buprenorphine\u003cbr\u003eChapter 6. Buprenorphine Treatment in Office-Based Settings\u003cbr\u003eChapter 7. Psychosocial and Supportive Treatment\u003cbr\u003eChapter 8. Referral, Logistics, and Diversion\u003cbr\u003eChapter 9. Methadone, Naltrexone, and Naloxone\u003cbr\u003eChapter 10. Psychiatric Comorbidity\u003cbr\u003eChapter 11. Medical Comorbidity\u003cbr\u003eChapter 12. Acute and Chronic Pain\u003cbr\u003eChapter 13. Opioid Use by Adolescents\u003cbr\u003eChapter 14. Women's Health and Pregnancy\u003cbr\u003eChapter 15. Comments on the Case Vignettes\u003cbr\u003eAppendix 1: Useful Web Sites and Recommended Readings\u003cbr\u003eAppendix 2: Buprenorphine and Office-Based Treatment of Opioid Use Disorder Supplemental Materials\u003cbr\u003eIndex\u003c\/p\u003e","brand":"American Psychiatric Association Publishing","offers":[{"title":"Default Title","offer_id":51863539450199,"sku":"9781615370832","price":56.7,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781615370832.jpg?v=1759920813","url":"https:\/\/bookcurl.com\/products\/office-based-buprenorphine-treatment-of-opioid-use-disorder-9781615370832","provider":"Book Curl","version":"1.0","type":"link"}